Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 253

1.

Should Unexplained Painful Physical Symptoms be Considered within the Spectrum of Depressive Symptoms?

Hong J, Novick D, Montgomery W, Aguado J, Dueñas H, Peng X, Haro JM.

Clin Pract Epidemiol Ment Health. 2015 Mar 31;11:130-9. doi: 10.2174/1745017901511010130. eCollection 2015.

2.

Real-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia.

Hong J, Novick D, Montgomery W, Moneta MV, Dueñas H, Peng X, Haro JM.

Asia Pac Psychiatry. 2015 Mar 24. doi: 10.1111/appy.12178. [Epub ahead of print]

PMID:
25808275
3.

Antidepressant medication treatment patterns in Asian patients with major depressive disorder.

Novick D, Montgomery W, Moneta V, Peng X, Brugnoli R, Haro JM.

Patient Prefer Adherence. 2015 Mar 11;9:421-8. doi: 10.2147/PPA.S68432. eCollection 2015.

4.

Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study.

Novick D, Hong J, Montgomery W, Dueñas H, Gado M, Haro JM.

Neuropsychiatr Dis Treat. 2015 Jan 22;11:197-205. doi: 10.2147/NDT.S75498. eCollection 2015.

5.

Impact of painful physical symptoms on depression outcomes in elderly Asian patients.

Novick D, Montgomery W, Bertsch J, Peng X, Brugnoli R, Haro JM.

Int Psychogeriatr. 2014 Nov 4:1-8. [Epub ahead of print]

PMID:
25366979
7.

Symptomatic remission and patient quality of life in an observational study of schizophrenia: is there a relationship?

Haro JM, Novick D, Perrin E, Bertsch J, Knapp M.

Psychiatry Res. 2014 Dec 15;220(1-2):163-9. doi: 10.1016/j.psychres.2014.07.034. Epub 2014 Aug 15.

PMID:
25194449
8.

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection.

Ascher-Svanum H, Novick D, Haro JM, Bertsch J, McDonnell D, Detke H.

Neuropsychiatr Dis Treat. 2014 Jun 20;10:1125-31. doi: 10.2147/NDT.S61409. eCollection 2014.

9.

Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia.

Peng X, Sun P, Novick D, Andrews J, Sun S.

J Pain Res. 2014 Jan 9;7:37-46. doi: 10.2147/JPR.S51636. eCollection 2014.

10.

Heparanase interacts with resistin and augments its activity.

Novick D, Barak S, Ilan N, Vlodavsky I.

PLoS One. 2014 Jan 21;9(1):e85944. doi: 10.1371/journal.pone.0085944. eCollection 2014.

11.

Real-world treatment patterns and opioid use in chronic low back pain patients initiating duloxetine versus standard of care.

Andrews JS, Wu N, Chen SY, Yu X, Peng X, Novick D.

J Pain Res. 2013 Nov 26;6:825-35. doi: 10.2147/JPR.S50323. eCollection 2013.

12.

Interleukin-18, more than a Th1 cytokine.

Novick D, Kim S, Kaplanski G, Dinarello CA.

Semin Immunol. 2013 Dec 15;25(6):439-48. doi: 10.1016/j.smim.2013.10.014. Epub 2013 Nov 22. Review.

PMID:
24275602
13.

Representativeness of obstetric patients who participate in perinatal depression research: findings from the Women's Mental Health and Infants Program (WMHIP) integrated dataset.

Novick DM, Allbaugh L, Zhao Z, Henshaw E, Vazquez DM, Armitage R, Flynn H; Women’s Mental Health and Infants Program (WMHIP).

Arch Womens Ment Health. 2014 Apr;17(2):97-105. doi: 10.1007/s00737-013-0385-4. Epub 2013 Nov 19.

PMID:
24248412
14.

Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia.

Hong J, Novick D, Treuer T, Montgomery W, Haynes VS, Wu S, Haro JM.

Patient Prefer Adherence. 2013 Sep 30;7:987-95. doi: 10.2147/PPA.S50628. eCollection 2013.

15.

Interleukin-18 and IL-18 binding protein.

Dinarello CA, Novick D, Kim S, Kaplanski G.

Front Immunol. 2013 Oct 8;4:289. doi: 10.3389/fimmu.2013.00289. Review.

16.

Predictors of psychiatric hospitalization during 6 months of maintenance treatment with olanzapine long-acting injection: post hoc analysis of a randomized, double-blind study.

Ascher-Svanum H, Novick D, Haro JM, Bertsch J, McDonnell D, Detke H.

BMC Psychiatry. 2013 Sep 16;13:224. doi: 10.1186/1471-244X-13-224.

17.

Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?

Novick D, Montgomery W, Kadziola Z, Moneta V, Peng X, Brugnoli R, Haro JM.

Patient Prefer Adherence. 2013 May 27;7:463-70. doi: 10.2147/PPA.S41703. Print 2013.

18.

Utilization of duloxetine and celecoxib in osteoarthritis patients.

Peng X, Wu N, Chen SY, Yu X, Andrews JS, Novick D.

Curr Med Res Opin. 2013 Sep;29(9):1161-9. doi: 10.1185/03007995.2013.816275. Epub 2013 Jul 10.

PMID:
23777314
19.

Changes in adherence and treatment costs following initiation of oral or depot typical antipsychotics among previously non-adherent patients with schizophrenia.

Hong J, Novick D, Brugnoli R, Bertsch J, Haro JM.

Hum Psychopharmacol. 2013 Sep;28(5):438-46. doi: 10.1002/hup.2328. Epub 2013 Jun 15.

PMID:
23775950
20.

Factors predicting hostility in outpatients with schizophrenia: 36-month results from the SOHO study.

Ochoa S, Suarez D, Novick D, Arranz B, Roca M, Baño V, Haro JM.

J Nerv Ment Dis. 2013 Jun;201(6):464-70. doi: 10.1097/NMD.0b013e31829480b0.

PMID:
23686157
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk